<DOC>
	<DOCNO>NCT00067756</DOCNO>
	<brief_summary>The purpose study find whether 4-PBA increase level AAT person AAT deficiency whether liver disease .</brief_summary>
	<brief_title>4-PBA : Will Increase Level Alpha 1-Antitrypsin ( AAT ) Persons With AAT Deficiency ?</brief_title>
	<detailed_description>The purpose study determine whether 4-PBA significantly increase serum Z AAT level AAT-deficient individual without evidence hepatocellular injury ass effect liver injury .</detailed_description>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>Age 1865 Serum A1PI level &lt; 11uM appropriate genetic phenotype/genotype 5 10 subject must document laboratory evidence liver disease Willingness withhold Prolastin therapy 6 week prior screen throughout 4PBA dose period ( 3 month ) Any cause liver disease Alpha1 Antitrypsin deficiency Evidence advance liver disease HIV positive Use systemic steroid , ursodeoxycholic acid ( Actigall , Urso ) , herbs prior 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Pulmonary Disease</keyword>
	<keyword>Liver Disease</keyword>
</DOC>